Ensysce Biosciences (ENSC) Non-Current Debt (2019 - 2025)
Ensysce Biosciences' Non-Current Debt came in at $140,148 for Q4 2022, down 96.8% from $4.44 million a year earlier and down 90.1% from the prior quarter.
Powered by 
Analysis
Ensysce Biosciences (ENSC) Non-Current Debt (2019 - 2025) Analysis & Trends
Going back to Q4 2019, Ensysce Biosciences' Non-Current Debt data covers 11 quarters.
- Non-Current Debt carries a three-year compound annual growth rate of -37.2% (FY2019 to FY2022).
- Going back by year, Non-Current Debt was $4.44 million in FY2021 (+684.2%), $566,288 in FY2020 (unchanged) and $566,288 in FY2019.
- The Q4 2022 figure represents the lowest quarterly Non-Current Debt in data going back to Q4 2019.
- Year-over-year, Non-Current Debt increased in two of the last four quarters, with growth averaging 206.9%.
- Business Quant data shows ENSC's Non-Current Debt at $1.41 million (Q3 2022), $360,797 (Q2 2022) and $1.59 million (Q1 2022) in the three quarters before Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 47.86 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 37.34 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 62.48 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 51.08 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 23.68 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 51.86 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 23.83 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 60.50 Bn |
| 10 | Ensysce Biosciences | 1.30 Mn | -9.94 Mn | - | 306,708.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 306,708.00 |
| Sep 30, 2025 | 387,702.00 |
| Jun 30, 2025 | 424,521.00 |
| Mar 31, 2025 | 257,383.00 |
| Dec 31, 2024 | 301,660.00 |
| Sep 30, 2024 | 387,176.00 |
| Jun 30, 2024 | 454,463.00 |
| Mar 31, 2024 | 245,973.00 |
| Dec 31, 2023 | 854,697.00 |
| Sep 30, 2023 | 350,932.00 |
| Jun 30, 2023 | 445,738.00 |
| Dec 31, 2022 | 4.55 Mn |
| Sep 30, 2022 | 11.74 Mn |
| Jun 30, 2022 | 3.15 Mn |
| Mar 31, 2022 | 10.12 Mn |
| Dec 31, 2021 | 25.28 Mn |
| Sep 30, 2021 | 7.98 Mn |
| Jun 30, 2021 | 466,055.00 |
| Dec 31, 2020 | 4.25 Mn |
| Sep 30, 2020 | 566,268.00 |
API Access
Ensysce Biosciences Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=ENSC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "ENSC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=ENSC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();